Navigation Links
Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
Date:5/22/2008

QUEBEC CITY, May 22 /PRNewswire-FirstCall/ - In accordance with the terms previously announced on April 4, 2008, Atrium Innovations Inc. "Atrium" (TSX: ATB) today announced that it has completed the sale of its Active Ingredients and Specialty Chemicals division for total proceeds of US$166.4 million in cash, subject to a post-closing working capital adjustment. Atrium is now a health and nutrition pure-play and the net proceeds from the transaction will provide the Company with better financial flexibility to pursue its corporate strategy.

About Atrium

Atrium Innovations Inc. is a recognized leading developer, manufacturer and marketer of science-based and professionally endorsed products for the health and nutrition industries. The Company focuses primarily on growing segments of the health and nutrition markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of finished products through its highly specialized sales and marketing network in more than 35 countries, primarily in North America and Europe. Atrium has over 575 employees and operates five manufacturing facilities. Additional information about Atrium is available on its Web site at http://www.atrium-innov.com.


'/>"/>
SOURCE Atrium Innovations Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Atrium Medical Receives FDA Approval for its Novel C-QUR Lite(TM) V-Patch and C-QUR Edge(TM) V-Patch
2. Atrium shows a strong financial performance for its first quarter
3. Atrium Innovations to Hold 2008 First Quarter Financial Results Conference Call and Webcast on May 6
4. Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29
5. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
6. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
7. Atrium Innovations Announces Management Changes
8. Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
9. SynCo Bio Partners Completes Manufacture and Release of ActoGeniX Lead Product for Phase II Clinical Trials
10. Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
11. China-Biotics, Inc. Completes Foundation for Its New Plant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...ISBANE, Calif., July 24 /- ...hat it will release second quarter 2008,financial ... July 31, 2008,at 4:00 p.m. Eastern time. A live c...Mune at 4:30 p.m. Eastern time that same day., To... (U.S.) or,706-634-0154 (international), conferenc...
(Date:7/24/2008)... Healthcare Technology Veteran to Help Spearhe...alth Monitoring Systems (HMS), (http://www.hmsinc....said today,that Karen S. Dockrell has been appoint...han 17 years of experience in sales, sales,managem...care technology,medical device and pharmaceutical...
(Date:7/24/2008)...DFORD, Mass., July 24 /- Ho...uccessful completion of the tender,offer by its di...for all,outstanding shares of Third Wave Technolog...r share in cash., The subsequent offering period ...Wednesday, July 23, 2008. The initial tender offer...
(Date:7/24/2008)...sue Dissection System Represents Important Advance... Technologies -, PALO ALTO, Calif., July 24 /PRNe...ompany that has developed a new tissue dissection ...nounced that the U.S. Food and,Drug Administration...t its,PEAK(R) Surgery System for use in general su...
Breaking Biology Technology:InterMune to Release Second Quarter 2008 Financial Results and Provide Business Update on July 31 2Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 3Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 4PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 4
... I recently participated in a roundtable discussio...ts were managers responsible for talent management... firms. The subject of discussion was agile resour...kforce more flexible. The goal of agile resourcing...have the right people, with the right skills, in t...
... Apple provides cluster computers to biology prof...SON A team of University of Wisconsin-Madison sta...uster for Bioinformatics awards . , ,Professor Mi...unduz Keles, Christina Kendziorski and Bret Larget... biological data. , ,Some of the fields they work ...
... MADISON Back in his math teacher days, Al Jacobs...lking about lily pads. Imagine a colony of lily pa...y: How long would it take for an area of two squar...are feet? , ,Only 17 days, thanks to the power of ... 32 and so on, until on the 17th day, 131,072 squa...
... What one thing, if done extremely well, is a powe...ogy commercialization organizations? And what, if ...e answer is delegation. How well you delegate will...ble to commercialize your technology. In this arti...ximize your technology commercialization marketing...
Other Biology Technology:Stuck in Talent Gridlock 2Stuck in Talent Gridlock 3Doubling the lily pads: Controlling the explosion in health care costs 2Doubling the lily pads: Controlling the explosion in health care costs 3Fire up your marketing by delegating 2
(Date:7/25/2008)...born with hydrocephalus, or "water on the brain" m...from the brain to reduce harmful pressure. , Wh...fection in children is very high for a variety of ...another surgery to replace the shunt, bringing wit...ological complications and an increased risk of de...
(Date:7/24/2008)...led by Massachusetts General Hospital (MGH) invest...mic research and medicine a robust method for gen...ar DNA sequences for inactivation or repair. In ...hers describe an efficient, publicly available met...ZFNs), which can be used to induce specific genomi...
(Date:7/24/2008)...by researchers from Columbia University,s Mailman ...challenging issues in infant health and preventing...s. In these settings, HIV-infected mothers had be...ants, they should exclusively breast-feed, followe...h. But according to the study conducted in Lusaka,...
(Date:7/24/2008)... researchers have found a molecular link between c...sm. The discovery reveals new possibilities for th... diseases. , Paolo Sassone-Corsi, Distinguished ...agues have identified that an essential protein ca...thms, works in balance with another protein called...
Breaking Biology News(10 mins):Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Consortium develops new method enabling routine targeted gene modification 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2New efficiency record for solar cells 5414 1New efficiency record for solar cells 5414 2Food 4 Less Expands Discounted Generic Drug Program 19403 1Food 4 Less Expands Discounted Generic Drug Program 19403 2Food 4 Less Expands Discounted Generic Drug Program 19403 3STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 1STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 2STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 3STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 4STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 5Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 19397 1Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 19397 2
...o speed development of new medical products throug...ug Administration (FDA) today issued a final guida...harmacogenomics allows health care providers to id...response and predict the best possible treatment o...sts are helping to identify cancers that have a go...
...rly detection of other tumors one day may be as si...cording to recent studies by UCLA researchers. , ...d here at the 96th Annual Meeting of the American ...ts reported that genetic "biomarkers" isolated in ...bout nine out of 10 cases. , A recent study by thi...
...sha National Park in northern Namibia, and ecologi...on for elephants. "It,s so fantastic here," she sa...bras, ostriches--it,s the Garden of Eden." , A re... of Medicine, O,Connell-Rodwell has come to one of... the mysterious and complex world of elephant comm...
...y,s Pratt School of Engineering have created a new...e. Inserted inside the esophagus, the probe create...s for current ultrasound technology to image a sin...derable potential not only for evaluating the cond...erapeutic treatment devices, the researchers said....
Other Biology News:FDA Works To Speed The Advent Of New, More Effective Personalized Medicines 2FDA Works To Speed The Advent Of New, More Effective Personalized Medicines 3Biomarkers isolated from saliva successfully predict oral and breast cancer 2Scientists journey to southern Africa to unravel the secret world of elephant communication 2Scientists journey to southern Africa to unravel the secret world of elephant communication 3Scientists journey to southern Africa to unravel the secret world of elephant communication 4Scientists journey to southern Africa to unravel the secret world of elephant communication 5Scientists journey to southern Africa to unravel the secret world of elephant communication 6Scientists journey to southern Africa to unravel the secret world of elephant communication 7Scientists journey to southern Africa to unravel the secret world of elephant communication 8Scientists journey to southern Africa to unravel the secret world of elephant communication 9Scientists journey to southern Africa to unravel the secret world of elephant communication 10Scientists journey to southern Africa to unravel the secret world of elephant communication 11Scientists journey to southern Africa to unravel the secret world of elephant communication 12Duke engineers develop new 3-D cardiac imaging probe 2
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity.
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles
Immunogen: Human Respiratory Syncytial Virus (RSV) and Bovine Respiratory Syncytial Virus (BRSV) Fusion protein Storage: -20 C, Avoid Freeze/Thaw Cycles
IHC detection kit for PCNA in cells and tissues
Biology Products: